UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 12, 2024
Accession Number:
0001654954-24-004524
Submission Type:
POS AM
CIK:
0000034956
Company Name:
TENAX THERAPEUTICS, INC.
File Number:
333-275856